drugset / Trial / NCT01451658

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

NCT01451658

Phase 4 Unknown 100 enrolled Taipei Veterans General Hospital, Taiwan
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients with hepatocellular carcinoma and esophageal varices bleeding were randomized to undergo endoscopic ligation alone (group A) and additive propranolol treatment (group B) after stabilization of their first acute bleeding.

Timeline

Start
2009-12
Primary completion
2020-07-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 20 mg